Illuminating Neurodegeneration: Advanced Molecular Imaging for Alzheimer’s and Parkinson’s Diagnosis and Treatment

Categories: Neuroscience
Wishlist Share
Share Course
Page Link
Share On Social Media

Course Content

Two distinguish spatiotemporal patterns of cerebral glucose hypometabolism in multiple system atrophy revealed by metabolic PET imaging

  • Two distinguish spatiotemporal patterns of cerebral glucose hypometabolism in multiple system atrophy revealed by metabolic PET imaging
    00:00

Scalable, automated neuromelanin-sensitive MRI measurement of nigral volume correlates with I-123 Ioflupane SPECT in Parkinson’s Disease

PET molecular imaging revealed Prussian blue nanozyme-mediated autophagy for pathogenic tau clearance in Alzheimer’s disease

Discovery and Evaluation of Imidazo[2,1-b][1,3,4]thiadiazole Derivatives as New Candidates for ?-Synuclein PET Imaging

Molecular Imaging for Visualization of NAD+-Dependent Deacetylase SIRT1 in Preclinical Animals

Pretargeted PET Imaging of Alzheimer’s Drug Distribution in the Brain using Click Chemistry